2023 Future Healthcare 100 Summit – Main Forum Sets Sail

In 2023, we are ushering in the inaugural year of industrial innovation, which also marks the first year for implementing the strategic arrangements of the 20th National Congress of the Communist Party of China and a critical year for advancing the 14th Five-Year Plan. In recent years, the pandemic has hindered development across various sectors; now, diverse forces are gearing up and poised for resurgence. Among them, the healthcare industry has ridden the tide of the times, leaping forward to stand at the crest of this wave.

Over the past six editions, the Future Healthcare 100 Conference has witnessed the continuous development of the healthcare industry. Meanwhile, the conference framework has been continuously upgraded, gradually evolving into an innovation ecosystem event that connects innovative enterprises, industrial capital, healthcare service institutions, research universities, and industrial parks.

In 2023,The 7th Future Healthcare Top 100 ConferenceUpgraded again, byVB100, VCBeat, Eggshell Research InstituteHosted by,Shanghai Zhangjiang GroupStrategic Cooperation Support, to be held atMay 5-7, 2023, at the Shanghai Zhangjiang Science HallGrandly Held. The conference features a three-day main forum, comprising the Trends Summit, the Leaders Summit, and the Top 100 Summit. By listening to the business insights of leading entrepreneurs in the industry, the event aims to outline future development trends for innovators, enhance industrial awareness, build the industry profile of innovative enterprises, and steer the direction of innovation and investment in China’s healthcare sector.

Currently, the perspective of the healthcare industry is focused on industrial development and trends within a global context. How can we grasp the direction of reforms in the drug regulatory, health administration, and medical insurance systems? What are the industry development trends from an investment perspective? This forum has invited senior researchers, renowned partners, experts from the National Health Commission, and other industry leaders to provide answers. Through insights shared by top-tier guests, innovators will gain visibility into the most influential cutting-edge technologies in medical innovation, enabling them to better understand future trends in the healthcare industry. The summit will address issues and strategies facing the healthcare sector through discussions centered on current challenges, industry visions, future trends, and pharmaceutical innovation.Focusing on Hot Industry Topics, Exploring New Development Opportunities,For example: Regarding the global expansion of domestically developed innovative drugs, what is the pathway for their overseas market approval? Technological advancements are driving new opportunities for innovation in healthcare.Prospects for a Healthy China in the Context of Population Aging, etc.

What are the challenges and innovations in the global market expansion of Chinese pharmaceutical companies? What are the industry outlooks and strategies of leading listed companies? The organizers of this Leadership Summit andIndustrial Securities Economic and Financial Research InstituteCo-hosted, the event has invited leading entrepreneurs from the healthcare industry to discuss future opportunities in the sector, business insights, and global innovation and strategic layout, sharing their corporate wisdom and strategies, such as:Trends in the Development and Practice of Digital Health Management,Organizational Challenges and Practices in the Globalization of Pharmaceutical Enterprises,Focusing on "Comprehensive Health Management" to Promote the Realization of Universal Health and Other Topics.

Shaping Industry Influence for Innovators, Building Brand Recognition for Enterprises. The primary objective of this Top 100 Summit is to identify the core forces driving the future of healthcare. Through keynote speeches by industry experts on the future development of the healthcare sector in a new era, Jixinyuanke’s clinical whole-genome sequencing for rare diseases, and the strategies behind leading enterprises’ inclusion in the Top 100, the summit brings new perspectives and opportunities to innovators. Experts addressed pressing concerns among innovators, such as the significant impact that disruptions in cancer screening services—caused by the cancellation or postponement of many screenings during the COVID-19 outbreak—may have on the entire healthcare system. Zhang Jiangli, Co-founder and CEO of Genetron Health, provided an in-depth discussion on the development trends of cancer screening in the post-pandemic era. Furthermore, as the Chinese government has consistently promoted the application of next-generation information technologies, including “Internet Plus,” big data, and artificial intelligence, in the medical field, the digital healthcare sector has been accelerating its development. Li Tiantian, Founder and Chairman of DXY, offered a detailed elaboration on the future trajectory of China’s digital healthcare. Benchmark enterprises shared their annual reviews and future innovation roadmaps, exploring collaboration and ecosystem building across the industry chain, including government, academia, research, and enterprise sectors, as well as industrial innovation and practices driven by the evolution of numerous emerging technologies.